Skip to content
lumiracoxib

Structure via PubChem · Public domain (PubChem)

EntityQ413744· pop 12· linked from 486 articles

lumiracoxib

Sign in to save

Also known as COX189, Prexige®, 2-((2-chloro-6-fluorophenyl)amino)-5-methylbenzeneacetic acid, COX 189, COX-189, Lumiracoxibum

Lumiracoxib is a COX-2 selective inhibitor nonsteroidal anti-inflammatory drug.

Chemical data

Formula
C15H13ClFNO2
Molecular weight
293.72 g/mol
IUPAC name
2-[2-(2-chloro-6-fluoroanilino)-5-methylphenyl]acetic acid
SMILES
CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O
InChIKey
KHPKQFYUPIUARC-UHFFFAOYSA-N
XLogP
4.2
Polar surface area
49.3 Ų
H-bond donors
2
H-bond acceptors
4
Formal charge
0

via PubChem

Drug data · ChEMBL

Withdrawn
Max clinical phase
Approved
Molecule type
Small molecule
First approval
2005
Admin. routes
oral
Indications
rheumatic disease, rheumatoid arthritis, osteoarthritis, hip, osteoarthritis, knee

via ChEMBL · EBI

Research

265 papers

via PubMed

Wikidata facts

Mass
293.062
Has use
medication
Show 7 more facts
chemical formula
C₁₅H₁₃ClFNO₂
canonical SMILES
CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O
World Health Organisation international non-proprietary name
lumiracoxib
defined daily dose
0.1
subject has role
COX-2 inhibitor
physically interacts with
Prostaglandin-endoperoxide synthase 2
Commons category
Lumiracoxib
Sources (4)

via Wikidata · CC0

~6 min read

Encyclopedic overview

4 sections
Contents
  • History
  • Withdrawal from market
  • References
  • External links

{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 408580996 | IUPAC_name = {2-[(2-chloro-6-fluorophenyl)amino]-5-methylphenyl}acetic acid | image = Lumiracoxib.svg | image_class = skin-invert-image | width = 180px

| tradename = Prexige | Drugs.com = | pregnancy_AU = C | legal_status = Rx-only, withdrawn (Australia, New Zealand, Canada, UK, Germany, Austria, Belgium, Cyprus, Brazil) | routes_of_administration = Oral

Excerpted from Wikipedia’s “lumiracoxib” article, available under the CC BY-SA 4.0 licence.